111 related articles for article (PubMed ID: 8223910)
1. Hexahydrobenzo[a]phenanthridines: novel dopamine D3 receptor ligands.
Watts VJ; Lawler CP; Knoerzer T; Mayleben MA; Neve KA; Nichols DE; Mailman RB
Eur J Pharmacol; 1993 Aug; 239(1-3):271-3. PubMed ID: 8223910
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
[TBL] [Abstract][Full Text] [Related]
3. Isomeric selectivity at dopamine D3 receptors.
Baldessarini RJ; Kula NS; McGrath CR; Bakthavachalam V; Kebabian JW; Neumeyer JL
Eur J Pharmacol; 1993 Aug; 239(1-3):269-70. PubMed ID: 8223909
[TBL] [Abstract][Full Text] [Related]
4. Locomotor inhibition, yawning and vacuous chewing induced by a novel dopamine D2 post-synaptic receptor agonist.
Smith HP; Nichols DE; Mailman RB; Lawler CP
Eur J Pharmacol; 1997 Mar; 323(1):27-36. PubMed ID: 9105873
[TBL] [Abstract][Full Text] [Related]
5. Iodinated 2-aminotetralins and 3-amino-1-benzopyrans: ligands for dopamine D2 and D3 receptors.
Chumpradit S; Kung MP; Vessotskie J; Foulon C; Mu M; Kung HF
J Med Chem; 1994 Nov; 37(24):4245-50. PubMed ID: 7990123
[TBL] [Abstract][Full Text] [Related]
6. In vitro binding of a novel dopamine D3 receptor ligand: [125I]trans-7-OH-PIPAT-A.
Kung MP; Kung HF; Chumpradit S; Foulon C
Eur J Pharmacol; 1993 Apr; 235(1):165-6. PubMed ID: 8519278
[TBL] [Abstract][Full Text] [Related]
7. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and evaluation of C9 alkoxy analogues of (-)-stepholidine as dopamine receptor ligands.
Madapa S; Gadhiya S; Kurtzman T; Alberts IL; Ramsey S; Reith M; Harding WW
Eur J Med Chem; 2017 Jan; 125():255-268. PubMed ID: 27688181
[TBL] [Abstract][Full Text] [Related]
9. Dopamine D2 and D3 receptors in the rat striatum and nucleus accumbens: use of 7-OH-DPAT and [125I]-iodosulpride.
Booze RM; Wallace DR
Synapse; 1995 Jan; 19(1):1-13. PubMed ID: 7709338
[TBL] [Abstract][Full Text] [Related]
10. S 14297, a novel selective ligand at cloned human dopamine D3 receptors, blocks 7-OH-DPAT-induced hypothermia in rats.
Millan MJ; Audinot V; Rivet JM; Gobert A; Vian J; Prost JF; Spedding M; Peglion JL
Eur J Pharmacol; 1994 Aug; 260(2-3):R3-5. PubMed ID: 7988633
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological aspects of R-(+)-7-OH-DPAT, a putative dopamine D3 receptor ligand.
Damsma G; Bottema T; Westerink BH; Tepper PG; Dijkstra D; Pugsley TA; MacKenzie RG; Heffner TG; Wikström H
Eur J Pharmacol; 1993 Nov; 249(3):R9-10. PubMed ID: 8287911
[TBL] [Abstract][Full Text] [Related]
12. The dopamine D3 receptor and 7-OH-DPAT.
Freedman JE; Waszczak BL; Cox RF; Liu JC; Greif GJ
Trends Pharmacol Sci; 1994 Jun; 15(6):173-4. PubMed ID: 7916508
[No Abstract] [Full Text] [Related]
13. Molecular basis for the binding of 2-aminotetralins to human dopamine D2A and D3 receptors.
Malmberg A; Nordvall G; Johansson AM; Mohell N; Hacksell U
Mol Pharmacol; 1994 Aug; 46(2):299-312. PubMed ID: 8078492
[TBL] [Abstract][Full Text] [Related]
14. [3H]7-OH-DPAT labels both dopamine D3 receptors and sigma sites in the bovine caudate nucleus.
Schoemaker H
Eur J Pharmacol; 1993 Oct; 242(3):R1-2. PubMed ID: 8281986
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of cis- and trans-9- and 11-hydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridines as structurally rigid, selective D1 dopamine receptor ligands.
Brewster WK; Nichols DE; Watts VJ; Riggs RM; Mottola D; Mailman RB
J Med Chem; 1995 Jan; 38(2):318-27. PubMed ID: 7830274
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of (R,S)-2'-trans-7-hydroxy-2-[N-n-propyl-N-(3'-iodo-2'- propenyl)-amino]tetralin (trans-7-OH-PIPAT): a new D3 dopamine receptor ligand.
Foulon C; Kung MP; Kung HF
J Med Chem; 1993 May; 36(10):1499-500. PubMed ID: 8098771
[No Abstract] [Full Text] [Related]
17. [3H]7-OH-DPAT is capable of labeling dopamine D2 as well as D3 receptors.
Gonzalez AM; Sibley DR
Eur J Pharmacol; 1995 Jan; 272(1):R1-3. PubMed ID: 7713138
[TBL] [Abstract][Full Text] [Related]
18. Analogues of doxanthrine reveal differences between the dopamine D1 receptor binding properties of chromanoisoquinolines and hexahydrobenzo[a]phenanthridines.
Cueva JP; Chemel BR; Juncosa JI; Lill MA; Watts VJ; Nichols DE
Eur J Med Chem; 2012 Feb; 48():97-107. PubMed ID: 22204903
[TBL] [Abstract][Full Text] [Related]
19. trans-hexahydroindolo[4,3-ab]phenanthridines ("benzergolines"), the first structural class of potent and selective dopamine D1 receptor agonists lacking a catechol group.
Seiler MP; Hagenbach A; Wüthrich HJ; Markstein R
J Med Chem; 1991 Jan; 34(1):303-7. PubMed ID: 1671417
[TBL] [Abstract][Full Text] [Related]
20. 1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma 3 receptor: further structure-activity relationships.
Wyrick SD; Booth RG; Myers AM; Owens CE; Bucholtz EC; Hooper PC; Kula NS; Baldessarini RJ; Mailman RB
J Med Chem; 1995 Sep; 38(19):3857-64. PubMed ID: 7562917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
